Trigen Intertan vs SHS RCT Version 1

  • Research type

    Research Study

  • Full title

    Functional Advantages of TRIGEN™ INTERTAN™ over Sliding Hip Screw in Subjects with Trochanteric Hip Fracture: A Randomised Controlled Trial

  • IRAS ID

    192415

  • Contact name

    Gayle Fyvie

  • Contact email

    gayle.fyvie@smith-nephew.com

  • Sponsor organisation

    Smith & Nephew Orthopaedics AG

  • Clinicaltrials.gov Identifier

    NCT03065101

  • Duration of Study in the UK

    2 years, 5 months, 31 days

  • Research summary

    This study is a randomised controlled trial comparing the Trigen Intertan Intramedullary Nail to Sliding Hip Screws in the treatment of intertrochanteric hip fractures (AO/OTA 31-A1 and A2). The study will involve several questionnaires (Functional Independence Measure, EuroQol-5D, Harris Hip Score and AM-PAC) to record data on functional recovery and quality of life as well as other outcome measures such as opioid usage, return to pre-injury residential and ambulatory status, radiological outcomes and a get-up and go test. Participating subjects will be randomised to one of the treatments and all will be followed up for one year post-surgery. The subjects will receive a daily assessment until discharge from hospital, telephone follow-ups at 8 weeks, 12 weeks and 12 months, and one outpatient follow-up visit at 6 months. The study hypothesis is that patients treated with Trigen Intertan will have a better score for the motor portion of the Functional Independence Measure at 8 weeks post-surgery.

  • REC name

    West of Scotland REC 4

  • REC reference

    16/WS/0006

  • Date of REC Opinion

    9 Mar 2016

  • REC opinion

    Further Information Favourable Opinion